<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on November 17, 2026 at 5:10 pm by All in One SEO Pro v5.0.5.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://sakaradigital.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Sakara Digital</title>
		<link><![CDATA[https://sakaradigital.com]]></link>
		<description><![CDATA[Sakara Digital]]></description>
		<lastBuildDate><![CDATA[Tue, 17 Nov 2026 20:34:05 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://sakaradigital.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://sakaradigital.com/blog/global-regulatory-harmonization-2026-fda-ema-pmda-biologics/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/global-regulatory-harmonization-2026-fda-ema-pmda-biologics/]]></link>
			<title>Global Regulatory Harmonization in 2026: Aligning FDA, EMA, and PMDA for Complex Biologics</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:34:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/cro-selection-in-the-ai-era/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/cro-selection-in-the-ai-era/]]></link>
			<title>CRO Selection in the AI Era</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:33:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/validating-genai-regulatory-document-authoring-playbook/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/validating-genai-regulatory-document-authoring-playbook/]]></link>
			<title>Validating GenAI for Regulatory Document Authoring: A Practical Playbook</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:33:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/annex-11-revision-readiness-gap-assessment-template/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/annex-11-revision-readiness-gap-assessment-template/]]></link>
			<title>Annex 11 Revision Readiness: A Gap Assessment Template</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:33:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/chain-of-identity-cell-therapy/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/chain-of-identity-cell-therapy/]]></link>
			<title>Chain of Identity for Cell Therapies: Digital Traceability from Patient to Product and Back</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:33:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/third-party-risk-management-pharma-vendor-ecosystems/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/third-party-risk-management-pharma-vendor-ecosystems/]]></link>
			<title>Third-Party Risk Management for Pharma: Building Resilient Vendor Ecosystems</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:32:46 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/digital-twins-clinical-trials-virtual-patient-models/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/digital-twins-clinical-trials-virtual-patient-models/]]></link>
			<title>Digital Twins in Clinical Trials: Virtual Patient Models Reshaping Drug Development</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:32:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/data-lakehouse-architecture-pharma/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/data-lakehouse-architecture-pharma/]]></link>
			<title>Data Lakehouse Architecture for Pharma: Unifying Clinical, Manufacturing, and Commercial Data</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:32:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/process-analytical-technology-pat-2026/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/process-analytical-technology-pat-2026/]]></link>
			<title>Process Analytical Technology (PAT) in 2026: From Compliance Tool to Manufacturing Intelligence Platform</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:32:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/validating-ai-agent-calls-other-systems/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/validating-ai-agent-calls-other-systems/]]></link>
			<title>Validating an AI Agent That Calls Other Systems: Scope, Boundaries, and Logs</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:31:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/10-20-70-rule-pharma-ai-success-people-process/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/10-20-70-rule-pharma-ai-success-people-process/]]></link>
			<title>The 10/20/70 Rule: Why Pharma AI Success Is 70% People and Process</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:31:39 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/bioprocessing-digital-twins/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/bioprocessing-digital-twins/]]></link>
			<title>Bioprocessing Digital Twins: Modeling Upstream and Downstream Operations for Process Optimization</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:31:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/ai-vendor-qualification-gxp/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/ai-vendor-qualification-gxp/]]></link>
			<title>Supplier Qualification for AI Vendors in GxP: Questions That Separate Evidence From Marketing</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:31:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/ich-m11-machine-readable-protocol-clinical-systems/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/ich-m11-machine-readable-protocol-clinical-systems/]]></link>
			<title>ICH M11 Is Final, Not Mandatory: What a Machine-Readable Protocol Changes for Clinical Systems</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:30:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/pharma-ai-pilots-fail-production-3/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/pharma-ai-pilots-fail-production-3/]]></link>
			<title>From AI Pilots to Production: Why 95% of Pharma AI Projects Fail</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:30:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/annex-11-annex-22-revisions-gxp-systems-ema-ai-data-integrity/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/annex-11-annex-22-revisions-gxp-systems-ema-ai-data-integrity/]]></link>
			<title>Annex 11 and Annex 22 Revisions: Preparing GxP Systems for EMA’s New AI and Data Integrity Rules</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:30:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/unlock-our-latest-white-paper-establishing-an-ai-policy/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/unlock-our-latest-white-paper-establishing-an-ai-policy/]]></link>
			<title>Establishing an AI Policy: A Comprehensive White Paper for Life Sciences Teams</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:30:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/ai-in-life-sciences-compliance-a-practical-guide-for-2026/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/ai-in-life-sciences-compliance-a-practical-guide-for-2026/]]></link>
			<title>AI in Life Sciences Compliance: A Practical Guide for 2026</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:30:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/fda-precheck-pilot-program-facility-engagement-pharma-manufacturing/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/fda-precheck-pilot-program-facility-engagement-pharma-manufacturing/]]></link>
			<title>FDA PreCheck Pilot Program: How Early Facility Engagement Accelerates Domestic Pharma Manufacturing</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:29:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/fair-data-principles-life-sciences/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/fair-data-principles-life-sciences/]]></link>
			<title>FAIR Data Principles for Life Sciences: Building Findable, Accessible, Interoperable, and Reusable Data Assets</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:29:36 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/master-data-management-life-sciences/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/master-data-management-life-sciences/]]></link>
			<title>Master Data Management for Life Sciences: Creating a Single Source of Truth Across Global Operations</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:29:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/eu-gene-therapy-standards-ema/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/eu-gene-therapy-standards-ema/]]></link>
			<title>EU Gene Therapy Standards: Navigating EMA&#8217;s Evolving Manufacturing and Quality Requirements</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:29:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/annex-22-mock-inspection-pharma-quality-practice/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/annex-22-mock-inspection-pharma-quality-practice/]]></link>
			<title>Annex 22 Mock Inspection: What a Pharma Quality Team Should Practice Now</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:28:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/implementing-black-mesa-gaip-mid-cap-pharma-objections/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/implementing-black-mesa-gaip-mid-cap-pharma-objections/]]></link>
			<title>Implementing Black Mesa GAIP in Mid-Cap Pharma: Common Objections and How to Handle Them</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:28:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/legacy-lims-modernization-three-path-decision-framework/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/legacy-lims-modernization-three-path-decision-framework/]]></link>
			<title>Legacy LIMS Modernization: A Three-Path Decision Framework</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:28:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/real-world-evidence-platform-selection-buyers-guide/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/real-world-evidence-platform-selection-buyers-guide/]]></link>
			<title>Real-World Evidence Platform Selection: A Buyer&#8217;s Guide</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:28:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/quantum-safe-cryptography-pharma-post-quantum-migration-timeline/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/quantum-safe-cryptography-pharma-post-quantum-migration-timeline/]]></link>
			<title>Quantum-Safe Cryptography for Pharma: The Post-Quantum Migration Timeline</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:28:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/one-health-data-standards-human-veterinary-pharma-systems-diverge/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/one-health-data-standards-human-veterinary-pharma-systems-diverge/]]></link>
			<title>One Health Data Standards: Where Human and Veterinary Pharma Systems Diverge</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:28:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/gaip-adme-tox-arpa-h-catalyst-nonclinical-data-integrity/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/gaip-adme-tox-arpa-h-catalyst-nonclinical-data-integrity/]]></link>
			<title>GAIP for ADME-Tox: What the ARPA-H CATALYST Work Means for Nonclinical Data Integrity</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:27:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/fda-ai-credibility-guidance-still-draft-what-to-do/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/fda-ai-credibility-guidance-still-draft-what-to-do/]]></link>
			<title>FDA&#8217;s AI Credibility Guidance Is Still a Draft: What to Do While You Wait</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:27:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/clinical-trial-data-standardization-beyond-sdtm/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/clinical-trial-data-standardization-beyond-sdtm/]]></link>
			<title>Clinical Trial Data Standardization Beyond SDTM</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:27:36 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/top-10-pharma-validated-first-production-llm-gxp/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/top-10-pharma-validated-first-production-llm-gxp/]]></link>
			<title>How a Top-10 Pharma Validated Its First Production LLM in a GxP Environment (Public Case Pattern)</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:27:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/ai-powered-pharmacovigilance-signal-detection-3/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/ai-powered-pharmacovigilance-signal-detection-3/]]></link>
			<title>AI-Powered Pharmacovigilance: Automating Signal Detection</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:27:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/quantum-computing-watch-list-pharma-rd-leaders/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/quantum-computing-watch-list-pharma-rd-leaders/]]></link>
			<title>Quantum Computing Watch List for Pharma R&#038;D Leaders</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:27:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/mes-vendor-landscape-2026-strategic-review/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/mes-vendor-landscape-2026-strategic-review/]]></link>
			<title>MES Vendor Landscape 2026: A Strategic Review</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:26:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/annex-22-final-text-what-to-settle-now/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/annex-22-final-text-what-to-settle-now/]]></link>
			<title>Annex 22 Final Text Is Still Pending: What to Settle Now and What to Wait For</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:26:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/validating-ai-systems-gxp-environments-3/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/validating-ai-systems-gxp-environments-3/]]></link>
			<title>Validating AI Systems in GxP Environments</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:26:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/fda-computer-software-assurance-csa-risk-based-validation/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/fda-computer-software-assurance-csa-risk-based-validation/]]></link>
			<title>FDA Computer Software Assurance (CSA): A Practical Guide to Risk-Based Validation</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:26:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/sbom-management-connected-medical-devices-fda-compliance/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/sbom-management-connected-medical-devices-fda-compliance/]]></link>
			<title>SBOM Management for Connected Medical Devices: From Compliance Requirement to Security Strategy</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:26:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/purolea-letter-pharma-first-ai-warning-gxp-compliance/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/purolea-letter-pharma-first-ai-warning-gxp-compliance/]]></link>
			<title>The Purolea Letter: What Pharma&#8217;s First AI Warning Means for GxP Compliance</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:26:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/ai-enabled-medical-device-lifecycle-management-premarket-submission-continuous-learning/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/ai-enabled-medical-device-lifecycle-management-premarket-submission-continuous-learning/]]></link>
			<title>AI-Enabled Medical Device Lifecycle Management: From Premarket Submission to Continuous Learning</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:25:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/21-cfr-part-11-age-of-ai/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/21-cfr-part-11-age-of-ai/]]></link>
			<title>21 CFR Part 11 in the Age of AI: What Still Applies</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:25:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/pharma-audit-trail-secret-weapon-context-graph-ai/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/pharma-audit-trail-secret-weapon-context-graph-ai/]]></link>
			<title>How Pharma&#8217;s Audit Trail Is the Secret Weapon for Context-Graph AI</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:25:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/black-mesa-gaip-progress-report-latest-draft/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/black-mesa-gaip-progress-report-latest-draft/]]></link>
			<title>Black Mesa GAIP Progress Report: What Is Public So Far and What It Signals</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:25:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/ema-annex-22-implementation-timeline-may-2026/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/ema-annex-22-implementation-timeline-may-2026/]]></link>
			<title>EMA&#8217;s Annex 22 Implementation Timeline: Where Pharma Sponsors Stand in May 2026</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:25:16 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/csa-implementation-changes-since-2024-2026-update/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/csa-implementation-changes-since-2024-2026-update/]]></link>
			<title>What&#8217;s Changed in CSA Implementation Since 2024: A Practical 2026 Update</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:25:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/adaptive-clinical-trial-designs-rare-disease-math/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/adaptive-clinical-trial-designs-rare-disease-math/]]></link>
			<title>Adaptive Clinical Trial Designs in Rare Disease: When the Math Works</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:24:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/tokenized-patient-data-rwe-what-works-2026/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/tokenized-patient-data-rwe-what-works-2026/]]></link>
			<title>Tokenized Patient Data for Real-World Evidence: What Works in 2026</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:24:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/real-world-data-governance-rwe-programs-2026-framework/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/real-world-data-governance-rwe-programs-2026-framework/]]></link>
			<title>Real-World Data Governance for RWE Programs: A 2026 Framework</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:24:39 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://sakaradigital.com/blog/data-product-owner-role-pharma-job-description-90-day-onboarding-plan/]]></guid>
			<link><![CDATA[https://sakaradigital.com/blog/data-product-owner-role-pharma-job-description-90-day-onboarding-plan/]]></link>
			<title>Data Product Owner Role in Pharma: Job Description and 90-Day Onboarding Plan</title>
			<pubDate><![CDATA[Tue, 17 Nov 2026 20:24:30 +0000]]></pubDate>
		</item>
				</channel>
</rss>
